Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. - Wikidata - wikimedia - TriplyDB

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q34620650

about

De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma Non-surgical interventions for human papilloma virus-positive local advanced oropharyngeal squamous cell cancer Interventions for preventing keratinocyte cancer in high-risk groups not receiving immunosuppressive therapy The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck The Indian scenario of head and neck oncology - Challenging the dogmas Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data.Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Advances in the management of squamous cell carcinoma of the head and neck.Diagnosis and management of head and neck cancers in a high-incidence area in France: A population-based study.Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives Prognostic factors in advanced pharyngeal and oral cavity cancer; significance of multimodality imaging in terms of 7th edition of TNM Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multi Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer.Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy.Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies.Transoral laser microsurgery or total laryngectomy for recurrent squamous cell carcinoma of the larynx: Retrospective analysis of 199 cases.Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy.Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.Cetuximab: its unique place in head and neck cancer treatment Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial Utility of MRI diffusion techniques in the evaluation of tumors of the head and neck.Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma.Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany.Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma Cetuximab in the treatment of squamous cell carcinoma of the head and neck.Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions.

P2860

Q24200362-0595EF09-4E98-401A-9CDA-F132D48F9830 Q24202687-9B00E3F2-2CCE-473A-9F25-AA54305E9C96 Q26471604-CAA25E3D-E7EE-4799-9537-B330A673659A Q26830495-DCA41E6A-EF0E-4489-A96B-99D9B34EEF6E Q28072546-938A8151-F7EB-4435-A727-794F2977DDC0 Q28076894-3B25BFEC-A147-44C2-AC08-12A84E9007C2 Q28080298-F989271B-D41B-4213-9BF6-C6CC3D2F4978 Q30919257-6F2EC62E-9847-4EEF-88B5-15EBEDEAB8AC Q33420293-2D1B9917-E019-4E1A-A477-BF0A5BA026C7 Q33650470-B3C34E72-28BF-447D-A723-B35FCEF803DA Q33720431-4CB23F27-F36C-4CF8-8E91-2C6D2E66ADD1 Q33879716-6A32D58C-5722-4A0F-BD1B-D48C61A8BE67 Q33884361-E4ED075A-CB0E-4BC6-BDB7-5056FC671A05 Q34667612-94A8D03F-75CD-4B9A-A574-63B1013BF252 Q34820775-43060BFE-1DDA-449E-8C1D-CE80AA7F0139 Q34946875-280D0925-A0F6-4556-83CF-55C8E9CA13F0 Q35034608-BCAC28B4-F954-46D3-9CCA-CB757C054CDA Q35091386-0D82308A-9CC3-41EF-92CC-0E170DF22F24 Q35189742-718F5DAC-2CD4-4AA5-8870-14EC41DEF7DC Q35652246-AC9C8C35-50FB-44DC-AD78-147C5656ACC3 Q35836618-55E56B0B-5CB3-4BEB-9DDE-A7597ED0B06C Q35991729-480C3AEB-0B86-4DE8-8FAE-46058AAAE6D8 Q36295084-9DB472D6-33BE-4059-A6DC-41C6456819A5 Q36300626-85E53079-AB23-4941-BF33-9980D2F6AC46 Q36452263-DCF2E8AA-4CE1-4DC1-956E-7361FE469BC8 Q36521194-BC06B27F-B6EF-452A-ACF4-D7AF6ECCB938 Q36544073-63101131-6CAE-474B-9E8C-E0515064E9AC Q36801917-A90024CB-50CA-4683-9418-2A5C3620A781 Q36801922-8F5D8B4C-8168-4DDC-9B8F-01015AE43B41 Q36880604-59E089FF-709E-4252-8BB7-F4E168DDE58D Q37022410-8785A30D-119A-4F91-B799-52AD1D3197CB Q37123921-1709DE48-CC90-4B8E-9730-77A7A64D0A57 Q37226499-219A8373-D551-436B-9C5D-7DCFE633115B Q37394723-1606D548-8FBC-4C0A-BEAB-4F3456408E55 Q37407202-8EAEE6C7-366C-4DF7-85B7-093616F9A87A Q37429990-1167A380-9C56-4E75-99BA-C6BAA97EBBAF Q37682460-6307257C-4202-4C26-AF7A-3AC15E1A393A Q37684506-EEB896F0-0AD5-4744-ACED-A6E88000265C Q37866779-C16A5A4F-CE1D-4B90-9C5A-16B3387AF33E Q37930893-82B46090-8BEC-4BFC-B04F-BF04E3C5764C

P2860

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q34620650

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@ast

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@en

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@nl

type

label

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@ast

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@en

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@nl

prefLabel

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@ast

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@en

Squamous cell carcinoma of the ...... osis, treatment and follow-up.

@nl

P1433

Q34620650-82AD2C2E-98DA-430E-BB3A-47F06028FA11

P1476

Q34620650-76A04D3F-AA44-41C9-82FD-EE131D187E21

P2093

Q34620650-55834B1B-35EE-4461-A7F3-F34968ECB32A

Q34620650-831195C0-A7BA-4E78-898F-E5947922C77C

Q34620650-F47F29DF-8829-43D5-819E-36748F795FC4

P2860

Q34620650-1C82CD90-2E09-40B9-9E0D-71A354A5C96B

Q34620650-272A1660-0035-4CBE-AC48-4B65235300A5

Q34620650-488CBDD0-A027-4214-9576-AA93B857F00F

Q34620650-62E9D99E-E8E6-43BB-B59F-DBD8185F4991

Q34620650-6EB25C1F-1CC5-4830-80AB-13164E7A07E3

Q34620650-7F3FFCDB-E5BF-439F-94AB-E6FEA9EDA9AE

Q34620650-B429FB4B-41E0-4E3A-974F-C59BB908B2A8

Q34620650-D321B288-3248-4C1E-9875-C7F578E0FC56

Q34620650-D9DE5900-0BC8-4D6C-8900-9267C077A748

Q34620650-EE62E357-CBD6-48FB-8528-843F5B4D6593

P304

Q34620650-6BA3F3B7-72BA-4F59-A50A-5C4AE8506DDB

P31

Q34620650-DB405B31-C876-42F0-B468-9331C3FA7A67

P356

Q34620650-1005348D-96A3-4549-BF82-3868F79110EC

P478

Q34620650-F96E8686-AA3C-4B89-8AE7-F76F737E86D0

P50

Q34620650-140E4084-106A-479B-820F-AB1D88154B2C

Q34620650-CE22306F-4690-48BA-B93E-609A9F60E9CB

P577

Q34620650-9C99BD78-2030-46D0-B24A-A71D80652D4B

P698

Q34620650-1541AA53-8D59-4574-903D-9BBDE2E947B4

P356

P1433

Annals of Oncology

P1476

Squamous cell carcinoma of the ...... nosis, treatment and follow-up

@en

P2093

EHNS-ESMO-ESTRO Guidelines Working Group

http://www.w3.org/2001/XMLSchema#string

J-L Lefebvre

http://www.w3.org/2001/XMLSchema#string

V Grégoire

http://www.w3.org/2001/XMLSchema#string

P2860

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

P304

v184-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDQ185

http://www.w3.org/2001/XMLSchema#string

P478

21 Suppl 5

http://www.w3.org/2001/XMLSchema#string

P50

Enriqueta Felip

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20555077

http://www.w3.org/2001/XMLSchema#string